Healthcare -
Biotechnology - NASDAQ - US
$ 3.94
2.07 %
$ 278 M
Market Cap
-2.42
P/E
CCCC - CAPITAL EXPENDITURES
Capital Expenditures CCCC - C4 Therapeutics, Inc.
-1.71 M
LAST VALUE
-15.65%
2 YEAR CAGR
8.68%
5 YEAR CAGR
0.00%
10 YEAR CAGR